Company Profile

GlaxoSmithkline Consumer Nigeria specializes in manufacturing and marketing pharmaceutical, hygiene and health care products. Net sales break down by activity as follows: - sale of consumer healthcare products (70.7%): nutritional supplements, OTC drugs and oral care products; - sale of drugs (29.3%): antibacterial drugs, prescription drugs and vaccines.

Employees

Sector

Pharmaceuticals

More about the company

31/10/23	GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
03/08/23	GSK Nigeria calls an end to its business, to return cash	RE
03/08/23	Glaxo Smithkline Consumer Nigeria To Cease Operations	RE
03/08/23	GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
28/04/23	GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
28/01/23	GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	CI
28/01/23	GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2022	CI
28/10/22	GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
29/07/22	GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
28/04/22	GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
31/01/22	GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Full Year Ended December 31, 2021	CI
25/10/21	GlaxoSmithKline Consumer Nigeria Plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
29/07/21	Glaxosmithkline Consumer Nigeria plc Reports Earnings Results for the Second Quarter Ended June 30, 2021	CI

03/11/23	GlaxoSmithKline Consumer Nigeria : GLAXO SMITHKLINE CONSUMER NIG. PLC.-COMPANY ANNOUNCEMENT	PU
31/10/23	GlaxoSmithKline Consumer Nigeria : GLAXO SMITHKLINE CONSUMER NIG. PLC.- QUARTER 3 - FINANCIAL STATEMENT FOR 2023	PU
14/08/23	Nigeria - a Requiem for Production? By Wole Olaoye [opinion]	AQ
03/08/23	GlaxoSmithKline Consumer Nigeria : GLAXO SMITHKLINE CONSUMER NIG. PLC.-COMPANY ANNOUNCEMENT	PU
03/08/23	GlaxoSmithKline Consumer Nigeria : GLAXO SMITHKLINE CONSUMER NIG. PLC.- QUARTER 2 - FINANCIAL STATEMENT FOR 2023	PU

Manager	Title	Age	Since
Olanike Olakanle CMP	Compliance Officer	-	-
Omolaja Odunuga CTO	Chief Tech/Sci/R&D Officer	-	01/08/2011
Omongiade Ehighebolo LAW	General Counsel	-	01/02/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GLAXOSMITHKLINE CONSUMER NIGERIA PLC	-.--%	-.--%	-	-	12.81M
ELI LILLY AND COMPANY	+7.13%	+9.97%	+55.80%	+160.09%	1,077B
JOHNSON & JOHNSON	+3.99%	+11.50%	+67.09%	+55.96%	613B
ABBVIE INC.	+4.20%	+17.03%	+38.97%	+91.06%	448B
ROCHE HOLDING AG	+0.99%	+4.85%	+28.17%	+23.89%	332B
ASTRAZENECA PLC	+1.82%	+8.19%	+40.04%	+27.95%	293B
NOVARTIS AG	+0.22%	+6.75%	+31.30%	+42.34%	286B
NOVO NORDISK A/S	+0.73%	+8.53%	-27.33%	-39.55%	215B
AMGEN INC.	+1.56%	+6.14%	+29.30%	+60.97%	193B
GILEAD SCIENCES, INC.	+3.26%	+3.33%	+15.55%	+68.24%	159B
Average	+2.39%	+8.00%	+30.99%	+54.55%	401.79B
Weighted average by Cap.	+3.85%	+8.93%	+41.75%	+80.17%

GlaxoSmithKline Consumer Nigeria Plc Stock

Stocks

GLAXOSMITH

NGGLAXOSMTH8

Pharmaceuticals

Latest news : GlaxoSmithKline Consumer Nigeria Plc

Press Releases: GlaxoSmithKline Consumer Nigeria Plc

News in other languages: GlaxoSmithKline Consumer Nigeria Plc

Managers and Directors: GlaxoSmithKline Consumer Nigeria Plc

Other Pharmaceuticals

Company Profile